| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name | Supply Food Supplement Raw Materials Natural Lactobacillus Rhamnosus |
| Appearance | White powder |
| Molecular formula | N/A |
| Molecular weight0 | 0 |
| Keywords | Lactobacillus Rhamnosus, Material Lactobacillus Rhamnosus; Pure Lactobacillus Rhamnosus |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
What is L-Rhamnose Monohydrate
Lactobacillus rhamnosus is a bacterium originally thought to be a subspecies of Lactobacillus casei, but genetic studies have revealed it to be a separate species in the evolutionary branch of Lactobacillus casei, which also includes Lactobacillus paracasei and Lactobacillus cornus. It is a short Gram-positive homotypic fermentative parthenogenic anaerobic non-spore-forming rod that often occurs in chains. Some Lactobacillus rhamnosus strains are used as probiotics and are particularly indicated for the treatment of female genitourinary tract infections, helping to regain control of flora overgrowth during active infections. L. rhamnosus is sometimes used in dairy products, such as fermented milk, and as a non-fermentable lactic acid bacteria (NSLAB) in long-ripened cheeses. Although often considered a beneficial organism, Lactobacillus rhamnosus may not be as beneficial to some populations; in rare cases, especially those primarily involving a weakened immune system or infants, it may cause endocarditis. Although Lactobacillus rhamnosus causes rare infections, this species is included in the European Food Safety Authority's list of bacterial species with Qualified Presumed Safe (QPS) status.
Function of L-Rhamnose Monohydrate
1) Pregnancy
Lactobacillus rhamnosus probiotic supplementation may reduce the incidence of gestational diabetes. Rhamnose also exerts anti-diabetic effects in mice and has anti-hyperglycemic effects in several rodent models. Rhamnose further improves glucose tolerance and increases sensitivity. Prenatal supplementation with Lactobacillus rhamnosus alters the composition of the neonatal microbiota, promoting a beneficial profile dominated by bifidobacteria. It has a positive impact on immune regulation and immune response in mothers and offspring. Furthermore, some of the beneficial effects of prenatal Lactobacillus rhamnosus supplementation extend to the offspring after birth, suggesting that Lactobacillus rhamnosus may have an immune programming effect. However, it is important to remember that pregnancy is a sensitive situation and each person's experience is different. If you are pregnant, please consult your doctor before using probiotics.
2) Intestinal Health
Lactobacillus rhamnosus is often chosen as a candidate probiotic for the prevention and treatment of gastrointestinal infections and diarrhea. It can reduce the duration of diarrhea, especially in children. It has also been shown to reduce the risk of daily doses of gastrointestinal infections in hospitalized children. Lactobacillus rhamnosus has been shown to reduce symptoms in children with functional gastrointestinal disorders . It is also beneficial in combating stress-induced intestinal motility disorders in mice .
3) Respiratory diseases
Fermented milk containing Lactobacillus rhamnosus is effective in reducing the risk of respiratory infections in hospitalized children lasting more than three days. The incidence of RTIs and rhinovirus-induced seizures appeared to be significantly reduced in preterm infants treated with daily Lactobacillus rhamnosus capsules starting within one week of birth for the first two months. Consumption of Lactobacillus rhamnosus reduces the incidence of respiratory illness in children in daycare centers. Lactobacillus rhamnosus has been shown to protect hospitalized patients from ventilator-associated pneumonia, mainly caused by gram-negative pathogens such as Pseudomonas aeruginosa. In patients with cystic fibrosis with Pseudomonas aeruginosa, long-term use of Lactobacillus rhamnosus significantly reduced the incidence of pulmonary deterioration and increased body weight.
4) Liver function
Lactobacillus rhamnosus restored liver function in obese children with NAFLD. Lactobacillus rhamnosus may prevent alcoholic liver injury. It protects mice from NAFLD by increasing beneficial bacteria in the distal small intestine and reducing hepatic fat accumulation and portal vein alanine aminotransferase concentrations.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}